Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Canaccord Genuity analyst William Plovanic initiated coverage on Artivion, Inc. (NYSE:AORT) with a Buy rating and announced a price target of $35. Artivion shares closed at $28.73 on Monday. See how other analysts view this stock.
- Citigroup analyst Geoff Meacham initiated coverage on Novavax, Inc. (NASDAQ:NVAX) with a Sell rating and …
Full story available on Benzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Canaccord Genuity analyst William Plovanic initiated coverage on Artivion, Inc. (NYSE:AORT) with a Buy rating and announced a price target of $35. Artivion shares closed at $28.73 on Monday. See how other analysts view this stock.
- Citigroup analyst Geoff Meacham initiated coverage on Novavax, Inc. (NASDAQ:NVAX) with a Sell rating and …
Full story available on Benzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Canaccord Genuity analyst William Plovanic initiated coverage on Artivion, Inc. (NYSE:AORT) with a Buy rating and announced a price target of $35. Artivion shares closed at $28.73 on Monday. See how other analysts view this stock.
Citigroup analyst Geoff Meacham initiated coverage on Novavax, Inc. (NASDAQ:NVAX) with a Sell rating and …Full story available on Benzinga.com Read MoreAORT, COIN, NVAX, TBPH, Top Initiations, VG, Initiation, Markets, Analyst Ratings, COIN, US21254S1078, NVAX, US6700021040, VG, US92886T2015, TBPH, AORT, Initiation, Markets, Analyst Ratings, Benzinga Markets
